OPK - OPKO Health, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.07
|
Rev Est: $139.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$1.60
DETAILS
HIGH:
$1.60
LOW:
$1.60
MEDIAN:
$1.60
CONSENSUS:
$1.60
UPSIDE:
39.13%
Market Cap:
882.86M
Volume:
2,263,014
Avg Volume:
3,226,586
52 Week Range:
1.11-2.04
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.49
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
2,997
IPO Date:
1995-11-02
EPS (TTM):
-0.08
P/E Ratio:
-19.17
Revenue (TTM):
713.14M
Total Assets:
2.20B
Total Debt:
504.44M
Cash & Equiv:
431.94M
Rev Growth (5Y):
-4.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
1.8%
Debt/Equity:
0.37
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-29 | $0.03 | $-0.02 | +250.0% | $151.7M | $139.8M | +8.5% |
| 2025-07-31 | $-0.19 | $-0.12 | -58.3% | $156.8M | $165.7M | -5.4% |
| 2025-04-30 | $-0.10 | $-0.06 | -66.7% | $150.0M | $165.7M | -9.5% |
| 2025-02-27 | $0.01 | $-0.08 | +112.5% | $183.6M | $155.4M | +18.2% |
| 2024-11-07 | $0.03 | $-0.10 | +130.0% | $173.6M | $155.4M | +11.7% |
| 2024-08-07 | $-0.01 | $-0.09 | +88.9% | $182.2M | $185.2M | -1.6% |
| 2024-05-07 | $-0.12 | $-0.09 | -33.3% | $173.7M | $183.0M | -5.1% |
| 2024-02-27 | $-0.09 | $-0.09 | 0.0% | $181.9M | $177.5M | +2.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 713.14M | 863.50M | 1.00B | 1.77B | 1.44B | 901.93M | 990.30M | 966.01M | 1.22B | 491.70M | 91.10M | 96.53M |
| Net Income | (53.22M) | (188.86M) | (328.40M) | (30.14M) | 30.59M | (314.93M) | (153.04M) | (305.25M) | (48.36M) | (30.03M) | (171.67M) | (114.41M) |
| EPS | -0.08 | -0.25 | -0.46 | -0.05 | 0.05 | -0.53 | -0.27 | -0.55 | -0.05 | -0.06 | -0.41 | -0.32 |
| Total Assets | 2.20B | 2.01B | 2.17B | 2.40B | 2.47B | 2.31B | 2.45B | 2.59B | 2.77B | 2.80B | 1.27B | 1.39B |
| Total Debt | 504.44M | 326.56M | 305.55M | 254.75M | 294.57M | 315.97M | 31.60M | 157.99M | 105.45M | 149.74M | 131.50M | 227.74M |
| Cash & Equivalents | 431.94M | 95.88M | 153.19M | 134.71M | 72.21M | 85.45M | 96.47M | 91.50M | 168.73M | 193.60M | 96.90M | 185.80M |
| Operating Cash Flow | (183.49M) | (28.20M) | (95.19M) | 38.34M | 39.48M | (172.52M) | (109.14M) | (92.08M) | 32.05M | 164.02M | (90.38M) | (58.19M) |
| Free Cash Flow | (208.50M) | (44.47M) | (119.77M) | 6.18M | 5.79M | (185.26M) | (137.00M) | (138.60M) | 8.50M | 148.18M | (95.11M) | (62.15M) |
| FCF per Share | -0.30 | -0.06 | -0.17 | 0.01 | 0.01 | -0.31 | -0.24 | -0.25 | 0.02 | 0.30 | -0.23 | -0.18 |
| Book Value | 1.37B | 1.39B | 1.56B | 1.69B | 1.67B | 1.61B | 1.79B | 1.84B | 2.09B | 1.98B | 835.80M | 876.41M |
| Cash & ST Investments | 431.94M | 95.88M | 153.19M | 134.71M | 72.21M | 85.45M | 96.50M | 91.50M | 168.70M | 193.60M | 96.90M | 185.80M |
| ROC Equity | -0.04 | -0.14 | -0.21 | -0.02 | 0.02 | -0.20 | -0.09 | -0.17 | -0.02 | -0.02 | -0.21 | -0.13 |